SHOULD WE REINTRODUCE PREVIOUS VENOUS THROMBOEMBOLISM INTO DECISION-MAKING FOR ANTICOAGULATION IN ATRIAL FIBRILLATION? A NATIONWIDE COHORT STUDY

Thure Filskov Overvad; Flemming Skjøth; Ida Ehlers Albertsen; Torben Bjerregaard Larsen; Mette Søgaard; Professor Gregory Lip

doi:10.1016/s0735-1097(20)32584-5

Back

SHOULD WE REINTRODUCE PREVIOUS VENOUS THROMBOEMBOLISM INTO DECISION-MAKING FOR ANTICOAGULATION IN ATRIAL FIBRILLATION? A NATIONWIDE COHORT STUDY

Article 2020 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Should We Reintroduce Previous Venous Thromboembolism Into Decision-Making for Anticoagulation in Atrial Fibrillation?

Thure Filskov Overvad, Flemming Skjøth, Ida Ehlers Albertsen, Torben Bjerregaard Larsen, Mette Søgaard, Professor Gregory Lip

Article2022

Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study

Anette Arbjerg Højen, Peter Brønnum Nielsen, Sam Riahi, Martin Bach Jensen, Professor Gregory Lip, Torben Bjerregaard Larsen, Mette Søgaard

Article2021

Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study

Daniele Pastori, A Marang, Arnaud Bisson, Danilo Menichelli, Julien Herbert, Professor Gregory Lip, Laurent Fauchier

Article2022

Thromboembolism and bleeding in patients with atrial fibrillation and liver disease – A nationwide register-based cohort study

Kamilla Steensig, Manan Pareek, Anne Lund Krarup, Peter Søgaard, Michael Mæng, Bhupendar Tayal, Christina Ji‐Young Lee, Christian Torp‐Pedersen, Professor Gregory Lip, Peter Holland‐Fischer, Kristian Kragholm

Article2024

Net Clinical Benefit of Oral Anticoagulation Among Frail Patients With Atrial Fibrillation: Nationwide Cohort Study

Mette Søgaard, Martin Jensen, Anette Arbjerg Højen, Torben Bjerregaard Larsen, Professor Gregory Lip, Anne Gulbech Ording, Peter Brønnum Nielsen